Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erminio Bonizzoni

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Cancer Medicine|March 27, 2025
NEPA (Netupitant/Palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients Receiving Highly or Moderately Emetogenic Chemotherapy Who Experienced Breakthrough CINV in Cycle 1 of Chemotherapy: A Phase II Clinical TrialRudolph M Navari, Erminio Bonizzoni
BJOG : an International Journal of Obstetrics and Gynaecology|September 25, 2002
Iron plus folate is more effective than iron alone in the treatment of iron deficiency anaemia in pregnancy: a randomised, double blind clinical trialJorge Juarez-Vazquez, Erminio Bonizzoni, Aurelio Scotti
Journal of Parkinson'S Disease|October 10, 2019
Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson's Disease PatientsCarlo Cattaneo, Wolfgang H Jost, Erminio Bonizzoni
Journal of Parkinson'S Disease|November 2, 2016
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc AnalysisCarlo Cattaneo, Paolo Barone, Erminio Bonizzoni, et al.
Future Oncology (London, England)|August 26, 2022
Efficacy of the dexamethasone-sparing triplet regimen for preventing cisplatin-induced emesis: a combined analysisLuigi Celio, Erminio Bonizzoni, Elena Montani, et al.
Journal of Parkinson'S Disease|September 26, 2015
Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson's Disease: A Post-Hoc AnalysisCarlo Cattaneo, R La Ferla, Erminio Bonizzoni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 7, 2015
Should clinicians always administer dexamethasone beyond 24 h after chemotherapy to control delayed nausea and vomiting caused by moderately emetogenic regimens? Insight from the re-evaluation of two randomized studiesLuigi Celio, Erminio Bonizzoni, Filippo De Braud, et al.
Thrombosis and Haemostasis|March 6, 2007
Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudicationPaolo Gresele, Rino Migliacci, Alessandra Procacci, et al.
Journal of Parkinson'S Disease|August 5, 2017
Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's DiseaseCarlo Cattaneo, Thomas Müller, Erminio Bonizzoni, et al.
Journal of Vascular Surgery|September 12, 2012
Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudicationPaolo Gresele, Rino Migliacci, Enrico Arosio, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Cancer Medicine|March 27, 2025
NEPA (Netupitant/Palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients Receiving Highly or Moderately Emetogenic Chemotherapy Who Experienced Breakthrough CINV in Cycle 1 of Chemotherapy: A Phase II Clinical TrialRudolph M Navari, Erminio Bonizzoni
BJOG : an International Journal of Obstetrics and Gynaecology|September 25, 2002
Iron plus folate is more effective than iron alone in the treatment of iron deficiency anaemia in pregnancy: a randomised, double blind clinical trialJorge Juarez-Vazquez, Erminio Bonizzoni, Aurelio Scotti
Journal of Parkinson'S Disease|October 10, 2019
Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson's Disease PatientsCarlo Cattaneo, Wolfgang H Jost, Erminio Bonizzoni
Journal of Parkinson'S Disease|November 2, 2016
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc AnalysisCarlo Cattaneo, Paolo Barone, Erminio Bonizzoni, et al.
Future Oncology (London, England)|August 26, 2022
Efficacy of the dexamethasone-sparing triplet regimen for preventing cisplatin-induced emesis: a combined analysisLuigi Celio, Erminio Bonizzoni, Elena Montani, et al.
Journal of Parkinson'S Disease|September 26, 2015
Long-Term Effects of Safinamide on Dyskinesia in Mid- to Late-Stage Parkinson's Disease: A Post-Hoc AnalysisCarlo Cattaneo, R La Ferla, Erminio Bonizzoni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 7, 2015
Should clinicians always administer dexamethasone beyond 24 h after chemotherapy to control delayed nausea and vomiting caused by moderately emetogenic regimens? Insight from the re-evaluation of two randomized studiesLuigi Celio, Erminio Bonizzoni, Filippo De Braud, et al.
Thrombosis and Haemostasis|March 6, 2007
Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudicationPaolo Gresele, Rino Migliacci, Alessandra Procacci, et al.
Journal of Parkinson'S Disease|August 5, 2017
Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's DiseaseCarlo Cattaneo, Thomas Müller, Erminio Bonizzoni, et al.
Journal of Vascular Surgery|September 12, 2012
Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudicationPaolo Gresele, Rino Migliacci, Enrico Arosio, et al.
Pageof 9